The role of 25-Hydroxyvitamin D in normal and disturbed calcium metabolism

European Journal of Clinical Investigation

Volumn 33, Issue 4, 2003, Pages 281-282

  Reichel, H ^a,c   Schmidt Gayk, H ^b  

^a Nephrological Center   (Germany)

^b Limbach Laboratory   (Germany)

^c Nephrological Center   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CALCITRIOL; PARATHYROID HORMONE;

BONE METABOLISM; BONE TURNOVER; CALCIUM METABOLISM; CHRONIC KIDNEY FAILURE; GRANULOMATOSIS; HORMONE SYNTHESIS; HUMAN; HYDROXYLATION; HYPERCALCEMIA; HYPERPARATHYROIDISM; NOTE; PRIORITY JOURNAL; RISK FACTOR; SARCOIDOSIS; SUNLIGHT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM;

CALCIUM; HUMANS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 0037393871     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2003.01166.x     Document Type: Note

References (13)

1. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet 1998;351:805-6.
2. Kudlacek S, Schneider B, Peterlik M, Leb G, Klaushofer K, Weber K et al. Assessment of vitamin D and calcium status in healthy adult Austrians. Eurp J Clin Invest 2003;33:323-31.
3. Docio S, Riancho JA, Perez A, Olmos JM, Amado JA, Gonzalez-Macias J. Seasonal deficiency of vitamin D in children: a potential target for osteoporosis-preventing strategies? J Bone Miner Res 1998;13:544-8.
4. 3 production by alveolar macrophages from normal donors and patients with sarcoidosis. J Clin Endocrinol Metab 1987;65:1201-9.
5. LoCascio V, Adami S, Galvanini G, Ferrari M, Cominacini L, Tartarotti D. Substrate-product relation of 1-hydroxylase activity in primary hyperparathyroidism. N Engl J Med 1985;313:1123-5.
6. Bayard F, Bec P, Ton That H, Louvet P. Plasma 25-hydroxycholecalciferol in chronic renal failure. Europ J Clin Invest 1973;3:447-50.
7. Ghazali A, Fardellone P, Pruna A, Atik A, Achard JM, Garabedian M et al. Low plasma 25OH vitamin D: a major risk factor for hyperparathyroidism and Looser's zone, independent of calcitriol. Kidney Int 1999;55:2169-77.
8. 3 metabolites in chronic renal failure and after renal transplantation. Nephrol Dial Transplant 1988;3:70-6.
9. 3. J Clin Endocrinol Metab 1984;59:1063-8.
10. Dusso D, Lopez-Hilker S, Rapp N, Slatopolsky E. Extra-renal production of calcitriol in chronic renal failure. Kidney Int 1988;34:368-75.
11. Turner RT, Puzas JE, Forte MD, Lester GE, Gray TK, Howard GA, et al. In vitro synthesis of 1α,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol by isolated calvarial cells. Proc Natl Acad Sci USA 1980;77:5720-4.
12. 3 (calcifediol) therapy of juvenile renal osteodystrophy: Beneficial effect on linear growth velocity. J Pediatrics 1982;100:815-20.
13. 3 in the osteomalacia of chronic renal failure. Clin Sci Molec Med 1977;52:499-508.